|
About LenDr. Pinchuk has 129 U.S. patents, 90 publications and founded 10 companies. His major accomplishments include the invention of the Nylon 12 angioplasty balloon, the helical wire stent, the modular stent-graft, a drug-eluting stent (TAXUS®), several biomaterials (Bionate® and SIBS), a novel glaucoma tube (the InnFocus MicroShunt®) and the next generation intraocular lens.
His inventions are used in hundreds of millions of patients with a financial impact well over $100 billion. He was inducted into the National Academy of Engineering in 2012, was awarded the 2017 Society for Biomaterials Innovation and Technology Award, San Antonio’s BIOMED SA Award (2017) and the National Academy of Engineering 2019 Fritz J. and Dolores H. Russ Prize. Dr. Pinchuk received a B.Sc. in chemistry from McGill University (1976) and a Ph.D. interdisciplinary in Engineering and Chemistry from the University of Miami (1984) and an honorary Doctorate of Science degree from McGill University in 2005. Dr. Pinchuk co-founded Corvita Corporation (1987) which went public in 1994, was acquired by Pfizer, Inc. (1996) and then sold to Boston Scientific (1998). He then founded Innovia LLC (2002), which spun-out InnFocus, Inc. (2004) which was acquired by Santen Pharmaceuticals in 2016. Dr. Pinchuk also enjoys an appointment as Distinguished Research Professor of Biomedical Engineering at the University of Miami. View all patents | View all publications |
Background and Accomplishments |
Dr. Pinchuk began his career in 1983 at Cordis Corporation and left in 1987 to co-found Corvita Corporation where the team developed the angioplasty balloon and pioneered the field of vascular and stent-grafts. After completing a successful IPO on the NASDAQ in 1994, Corvita was purchased by Pfizer, Inc. (1996) and then sold to Boston Scientific (1998).
His major accomplishments include the invention or co-invention of the modern-day angioplasty balloon, the helical stent used on most stent-grafts, the modular stent-graft used to repair abdominal aortic aneurysms, polycarbonate urethanes for use in medicine, SIBS for implant applications, Boston Scientific Corporation’s TAXUS drug-eluting coronary stent, the InnFocus MicroShunt® for the treatment of glaucoma, the Surefire Catheter for treating liver tumors, the Mayser urinary drainage catheter and the next generation intraocular lens material. View complete list of patents. |
Honors and Awards |
|
Education |
Dr. Pinchuk received a B.Sc. in chemistry from McGill University in 1976, a Ph.D. interdisciplinary in Engineering and Chemistry from the University of Miami in 1984.
|
